Certified by Founder Lodge
Grey Wolf Therapeutics
United Kingdom - Milton, Oxfordshire
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology and founded by experienced industry professionals Tom McCarthy (Executive Chairman), forme
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 23 ,2024 | Series B | $50,000,000 |
Oxford Science Enterprises
Canaan
Pfizer
Andera Partners
British Patient Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
Fanvue | $22,000,000 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
Fleetzero | $43,000,000 | (Jan 20, 2026)
